These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17002217)

  • 1. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor modulators as cognitive enhancers.
    Lynch G
    Curr Opin Pharmacol; 2004 Feb; 4(1):4-11. PubMed ID: 15018832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?
    Yamada KA
    Neurobiol Dis; 1998 Aug; 5(2):67-80. PubMed ID: 9746904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPA receptor potentiators as cognitive enhancers.
    O'Neill MJ; Dix S
    IDrugs; 2007 Mar; 10(3):185-92. PubMed ID: 17351873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory mechanisms of AMPA receptors in synaptic plasticity.
    Derkach VA; Oh MC; Guire ES; Soderling TR
    Nat Rev Neurosci; 2007 Feb; 8(2):101-13. PubMed ID: 17237803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.
    Mellor IR
    Future Med Chem; 2010 May; 2(5):877-91. PubMed ID: 21426207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins.
    Strømgaard K; Mellor I
    Med Res Rev; 2004 Sep; 24(5):589-620. PubMed ID: 15224382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.
    Grove SJ; Jamieson C; Maclean JK; Morrow JA; Rankovic Z
    J Med Chem; 2010 Oct; 53(20):7271-9. PubMed ID: 20839777
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
    Raevskiĭ KS; Eremin KO
    Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for AMPA receptors in mood disorders.
    Alt A; Nisenbaum ES; Bleakman D; Witkin JM
    Biochem Pharmacol; 2006 Apr; 71(9):1273-88. PubMed ID: 16442080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.
    Siuda ER; Quirk JC; Nisenbaum ES
    Methods Mol Biol; 2007; 403():37-57. PubMed ID: 18827986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA receptor potentiators for the treatment of CNS disorders.
    O'Neill MJ; Bleakman D; Zimmerman DM; Nisenbaum ES
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):181-94. PubMed ID: 15180479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural aspects of AMPA receptor activation, desensitization and deactivation.
    Hansen KB; Yuan H; Traynelis SF
    Curr Opin Neurobiol; 2007 Jun; 17(3):281-8. PubMed ID: 17419047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and different conformational states of native AMPA receptor complexes.
    Nakagawa T; Cheng Y; Ramm E; Sheng M; Walz T
    Nature; 2005 Feb; 433(7025):545-9. PubMed ID: 15690046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structure of an AMPA receptor without associated stargazin/TARP proteins.
    Nakagawa T; Cheng Y; Sheng M; Walz T
    Biol Chem; 2006 Feb; 387(2):179-87. PubMed ID: 16497150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
    Hald H; Ahring PK; Timmermann DB; Liljefors T; Gajhede M; Kastrup JS
    J Mol Biol; 2009 Sep; 391(5):906-17. PubMed ID: 19591837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
    Yang CR; Svensson KA
    Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.
    Chang PK; Verbich D; McKinney RA
    Eur J Neurosci; 2012 Jun; 35(12):1908-16. PubMed ID: 22708602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.